Question 1

What is the catalog number for Compound STOCK1N-51404?

Accepted Answer

The catalog number for Compound STOCK1N-51404 is T127085.

Question 2

Is Compound STOCK1N-51404 in stock?

Accepted Answer

Compound STOCK1N-51404 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Who manufactures Compound STOCK1N-51404?

Accepted Answer

Compound STOCK1N-51404 is manufactured by Molfinity.

Question 4

What is the estimated delivery time for Compound STOCK1N-51404?

Accepted Answer

Estimated delivery time for Compound STOCK1N-51404 is approximately 10 business day(s), depending on your location.

Question 5

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

Question 6

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Question 7

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Compound STOCK1N-51404

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

L-Aspartic Acid

HYDIN Human Gene Knockout Kit (CRISPR)

Cytokeratin 5/6/18 (LP34), CF405S conjugate, 0.1mg/mL

Tissue Total RNA, Lung

MALT1 (MALT-Lymphoma Marker) (MT1/3159R), CF405S conjugate, 0.1mg/mL

Human SLC44A4 activation kit by CRISPRa